ABEONA THERAPEUTICS INC. Public Float
ABEONA THERAPEUTICS INC. (ABEO) had Public Float of $273.25 million as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $273.25M.
- 2024-06-30: Entity Public Float $170.90M.
- 2023-06-30: Entity Public Float $78.47M.
- 2022-06-30: Entity Public Float $28.75M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $273.25M 10-K · filed 2026-03-17 |
| 2024-06-30 | $170.90M 10-K · filed 2025-03-20 |
| 2023-06-30 | $78.47M 10-K · filed 2024-03-18 |
| 2022-06-30 | $28.75M 10-K/A · filed 2023-04-10 |
| 2021-06-30 | $137.20M 10-K · filed 2022-03-31 |
| 2020-06-30 | $204.16M 10-K · filed 2021-03-24 |
| 2019-06-30 | $131.28M 10-K · filed 2020-03-16 |
| 2018-06-30 | $445.13M 10-K · filed 2019-03-18 |
| 2017-06-30 | $162.49M 10-K · filed 2018-03-16 |
| 2016-06-30 | $41.68M 10-K · filed 2017-03-30 |
| 2015-06-30 | $74.70M 10-K · filed 2016-03-30 |
| 2014-06-30 | $22.08M 10-K · filed 2015-03-31 |
| 2013-06-30 | $12.15M 10-K · filed 2014-03-26 |
| 2012-06-30 | $15.64M 10-K · filed 2013-03-20 |
| 2011-06-30 | $39.54M 10-K · filed 2012-03-23 |
| 2010-06-30 | $22.20M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |